A safe serum range is 200350 ng/L, depending on age and clinical condition
The dual GIP/GLP-1 receptor agonist has shown superior efficacy in weight reduction and metabolic improvement, and its European rollout marks a significant milestone in expanding the availability of next-generation obesity drugs beyond the U.S
Int J Mol Sci 25(8):4272 Gilles A, Ihtijarevic B, Wouters K, Van de Heyning P (2014) Using prophylactic antioxidants to prevent noise-induced hearing damage in young adults: a protocol for a double-blind, randomized controlled trial
The product targets the trillions of bacteria in the gastrointestinal tract that influence digestion, immunity, metabolism, and even mental clarity
(FYI, participants were not on any other diabetes medications at the start of the trial.) Participants also had an average weight loss of 4.5%7.6% over the same period, with those who took higher doses experiencing the higher end of the range of weight loss
Pharm Biol (2014) 52:26871